Clinical trial
Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With…
NCT00234052 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00234052 |
|---|---|
| Title | Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer |
| Official title | Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug |
| Interventions | bevacizumab, carboplatin, pemetrexed |
| Enrollment | 51 |
| Start date | Jul 28, 2005 |
| Primary completion | Mar 1, 2011 |
| Completion | Nov 28, 2011 |
| First posted | Oct 6, 2005 |
| Last update posted | Jun 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: